Voom Medical Devices Welcomes Dr. Joël Vernois as Advisor and Editor-in-Chief of Journal of Minimally Invasive Bunion Surgery (JMIBS)

NEW YORK–(BUSINESS WIRE)–#bunionplasty–Voom™ Medical Devices, Inc. (“Voom”), a visionary medical device company focused on new paradigms in minimally invasive bunion surgery (MIBS), is honored to announce that Dr. Joël Vernois has joined the Voom leadership team as an advisor on modern MIBS techniques and technology. Dr. Vernois will also spearhead a new publication dedicated to advancements in MIBS.




Dr. Vernois is a leading innovator in minimally invasive surgery (MIS) techniques, with more than two decades of clinical, industry, and academic experience. He has pioneered multiple MIS procedures, including chevron osteotomies and midfoot and hindfoot techniques. Dr. Vernois advanced the state of minimally invasive distal bunion surgery in developing a novel technique and surgical implant, while setting the stage for continued innovation in the field. As a global educator and expert in training surgeons in MIS techniques, Dr. Vernois offers deep insight into both the newest MIBS procedures and the path to achieving reproducible results.

“Voom is a medical technology company founded by surgeons, for surgeons, and our work will benefit tremendously from Dr. Vernois’ perspective,” notes Dr. Neal Blitz, DPM, FACFAS, Voom Founder and CEO. “His expertise will not only help us drive surgical innovation – together, we’re working to advance the state of education and thought leadership in our field.”

Dr. Vernois will serve as Editor-in-Chief of the Journal of Minimally Invasive Bunion Surgery (JMIBS), an open-access, free publication made possible by Voom. JMIBS is a resource for practicing surgeons who want to keep up with the most cutting-edge developments in MIBS procedures, technology, and practices. The journal is the first to focus on this rapidly evolving field of bunion repair.

“Minimally invasive bunion surgery is the future, and it is critical that there be publications dedicated to studying it, and to making that information accessible,” affirms Dr. Vernois. “This is where clinicians will go to both consume and provide the latest literature around MIBS. By streamlining how we share innovation, we are streamlining the process of innovation itself.”

Those interested in learning more about this emerging publication can visit the Journal of Minimally Invasive Bunion Surgery. For comprehensive information about Voom Medical Devices and its revolutionary No-Fusion Bunion Solution™, and other innovations, please visit www.voommedicaldevices.com or contact [email protected].

About Voom Medical Devices, Inc.

Voom Medical Devices, Inc. is a rapidly growing orthopedic medical device company specializing in innovative solutions for minimally invasive bunion surgery (MIBS). Established in 2017, Voom is committed to advancing fusion-free bunion solutions, fostering surgical innovation, and ensuring the highest standards of patient care. Visit www.voommedicaldevices.com to learn more.

Contacts

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.